Diego A. Chiappetta

4.6k total citations
87 papers, 3.7k citations indexed

About

Diego A. Chiappetta is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Biology. According to data from OpenAlex, Diego A. Chiappetta has authored 87 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pharmaceutical Science, 23 papers in Biomaterials and 16 papers in Molecular Biology. Recurrent topics in Diego A. Chiappetta's work include Advanced Drug Delivery Systems (21 papers), Nanoparticle-Based Drug Delivery (21 papers) and HIV/AIDS drug development and treatment (9 papers). Diego A. Chiappetta is often cited by papers focused on Advanced Drug Delivery Systems (21 papers), Nanoparticle-Based Drug Delivery (21 papers) and HIV/AIDS drug development and treatment (9 papers). Diego A. Chiappetta collaborates with scholars based in Argentina, United Kingdom and Colombia. Diego A. Chiappetta's co-authors include Alejandro Sosnik, Marcela A. Morettón, Ezequiel Bernabeu, Maximiliano Cagel, Christián Höcht, Carlos A. Taira, Estefanía Grotz, Eduardo Lagomarsino, Lorena González and Ángel M. Carcaboso and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and International Journal of Molecular Sciences.

In The Last Decade

Diego A. Chiappetta

85 papers receiving 3.6k citations

Peers

Countries citing papers authored by Diego A. Chiappetta

Since Specialization

Citations

This map shows the geographic impact of Diego A. Chiappetta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego A. Chiappetta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego A. Chiappetta more than expected).

Fields of papers citing papers by Diego A. Chiappetta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego A. Chiappetta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego A. Chiappetta. The network helps show where Diego A. Chiappetta may publish in the future.

Co-authorship network of co-authors of Diego A. Chiappetta

This figure shows the co-authorship network connecting the top 25 collaborators of Diego A. Chiappetta. A scholar is included among the top collaborators of Diego A. Chiappetta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego A. Chiappetta. Diego A. Chiappetta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Contrasting Effect of Curcumin on Hepatitis B Virus Replication According to the Hepatoma Cell Line 2025 ·Pathogens ·María Mercedes Elizalde, (unknown), Diego A. Chiappetta, Diego Flichman	1
2	Development of a new micellar formulation of carvedilol and curcumin to enhance blood pressure reduction in a spontaneously hypertensive rat model 2024 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mariana Garcés, Pablo Evelson, Susana Gorzalczany, Andrea Carranza, (unknown), Diego A. Chiappetta	1
3	Soluplus® nanomicelles enhance IgG neutralizing properties against Shiga toxin type 2 2024 ·Journal of Drug Delivery Science and Technology ·(unknown), (unknown), (unknown), José M. Delfino, Fernando Gómez, Cristina Ibarra, María Marta Amaral, Diego A. Chiappetta, Marcela A. Morettón, (unknown)	1
4	Polymeric Nanomicelles Loaded with Anandamide and Their Renal Effects as a Therapeutic Alternative for Hypertension Treatment by Passive Targeting 2023 ·Pharmaceutics ·Virna Margarita Martín Giménez, Marcela A. Morettón, Diego A. Chiappetta, María Jimena Salgueiro, Miguel W. Fornés, Walter Manucha	5
5	Characterization and bioavailability of a novel coenzyme Q10 nanoemulsion used as an infant formula supplement 2023 ·International Journal of Pharmaceutics ·(unknown), Ana M. Rojas, Christián Höcht, Ezequiel Bernabeu, Diego A. Chiappetta, (unknown), Silvia Lucangioli, Sabrina Flor, Valeria Trípodi	7
6	Detection and characterization of circulating microvesicles containing Shiga toxin type 2 in a rat model of Hemolytic Uremic Syndrome 2023 ·Toxicon ·(unknown), (unknown), Carolina Jancic, (unknown), (unknown), Marcela A. Morettón, Diego A. Chiappetta, Cristina Ibarra, María Marta Amaral	0
7	Chitosan-Based Nanogels Designed for Betanin-Rich Beetroot Extract Transport: Physicochemical and Biological Aspects 2023 ·Polymers ·(unknown), (unknown), Marcela A. Morettón, Leonardo Lizárraga, Diego A. Chiappetta, Agustina Alaimo, Oscar E. Pérez	13
8	Dual strategy to improve the oral bioavailability of efavirenz employing nanomicelles and curcumin as a bio-enhancer 2023 ·International Journal of Pharmaceutics ·(unknown), Ezequiel Bernabeu, (unknown), Mariana Garcés, (unknown), Marcela Zubillaga, Pablo Evelson, María Jimena Salgueiro, Marcela A. Morettón, Christián Höcht, Diego A. Chiappetta	10
9	Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy 2022 ·Pharmaceutics ·Juan Manuel Galdopórpora, (unknown), Ezequiel Bernabeu, (unknown), (unknown), Ines Castangia, María Letizia Manca, Mariana Garcés, Juan M. Lázaro‐Martínez, María Jimena Salgueiro, Pablo Evelson, Nancy Liliana Tateosian, Diego A. Chiappetta, Marcela A. Morettón	30
10	The Topical Nanodelivery of Vismodegib Enhances Its Skin Penetration and Performance In Vitro While Reducing Its Toxicity In Vivo 2021 ·Pharmaceutics ·María Natalia Calienni, (unknown), (unknown), (unknown), (unknown), Ezequiel Bernabeu, Marcela A. Morettón, (unknown), Diego A. Chiappetta, S. Alonso, María Jimena Prieto, Jorge Montanari	9
11	Paclitaxel: What has been done and the challenges remain ahead 2017 ·International Journal of Pharmaceutics ·Ezequiel Bernabeu, Maximiliano Cagel, Eduardo Lagomarsino, Marcela A. Morettón, Diego A. Chiappetta	309
12	Acute effects of third generation β-blockers on short-term and beat-to-beat blood pressure variability in sinoaortic-denervated rats 2013 ·Hypertension Research ·(unknown), (unknown), (unknown), Diego A. Chiappetta, Ariel H. Polizio, Carlos A. Taira, Christián Höcht	12
13	Single and mixed poloxamine micelles as nanocarriers for solubilization and sustained release of ethoxzolamide for topical glaucoma therapy 2012 ·Journal of The Royal Society Interface ·Andreza Maria Ribeiro, Alejandro Sosnik, Diego A. Chiappetta, Francisco Veiga, Ángel Concheiro, Carmen Alvarez‐Lorenzo	70
14	Inhibition of fluconazole in vitro antifungal activity in formulations containing propylene glycol 2011 ·Latin American Journal of Pharmacy ·(unknown), (unknown), Diego A. Chiappetta, Carlos Bregni	3
15	Influence of surfactant structure in the encapsulation and stability of amphotericin B in niosomes 2011 ·Latin American Journal of Pharmacy ·(unknown), Diego A. Chiappetta, (unknown), Carlos Bregni	4
16	Efavirenz is a substrate and in turn modulates the expression of the efflux transporter ABCG2/BCRP in the gastrointestinal tract of the rat 2011 ·Biochemical Pharmacology ·(unknown), (unknown), Christián Höcht, Diego A. Chiappetta, Carlos Rubio-Terrés, Alejandro Sosnik, Guillermo F. Bramuglia	41
17	Carvedilol stability in paediatric oral liquid formulations 2010 ·Farmacia Hospitalaria ·(unknown), Ezequiel Bernabeu, Romina J. Glisoni, Eduardo Quiroga, Carlos Bregni, Diego A. Chiappetta	15
18	Poly(ethylene oxide)–poly(propylene oxide) block copolymer micelles as drug delivery agents: Improved hydrosolubility, stability and bioavailability of drugs 2007 ·European Journal of Pharmaceutics and Biopharmaceutics ·Diego A. Chiappetta, Alejandro Sosnik	487
19	Comprimidos bioadhesivos formulados con excipientes hidrofílicos para uso bucofaríngeo 2006 ·El Servicio de Difusión de la Creación Intelectual (National University of La Plata) ·Diego A. Chiappetta, (unknown), (unknown), (unknown), (unknown), Carlos Bregni	2
20	Los copolímeros en bloques anfifílicos y sus aplicaciones farmacéuticas 2005 ·El Servicio de Difusión de la Creación Intelectual (National University of La Plata) ·(unknown), Diego A. Chiappetta, Carlos Bregni	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact